SEI Investments’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

SEI Investments’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-16,908	Closed	-$192K	–	2648
2021 Q2	$192K	Buy	+16,908	New	+$170K	﹤0.01%	2452
2017 Q4	–	Sell	-1	Closed	–	–	3528
2017 Q3	$0	Hold	1	–	–	﹤0.01%	3428
2017 Q2	$0	Hold	1	–	–	﹤0.01%	3324
2017 Q1	$0	Hold	1	–	–	﹤0.01%	3109
2016 Q4	$0	Hold	1	–	–	﹤0.01%	3075
2016 Q3	$0	Hold	1	–	–	﹤0.01%	3015
2016 Q2	$0	Buy	+1	New	+$111	﹤0.01%	2779

Other funds holding VIRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SEI Investments's VIRX Position: Q3 2021 in Review

SEI Investments sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q3 2021, closing a stake of 16,908 shares — an estimated $192K sold.

SEI Investments first reported a position in VIRX in Q2 2016 and held it in 7 quarters. The position peaked at $192K in Q2 2021. 68 funds tracked by Wall St. Rank hold VIRX as of Q3 2021.

SEI Investments reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
SEI Investments sold 16,908 Viracta Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $192K.
SEI Investments first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2016 and held it in 7 quarters.
SEI Investments's Viracta Therapeutics, Inc. Common Stock position peaked at $192K in Q2 2021.
68 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q3 2021.

Based on SEI Investments's 13F filing for Q3 2021, filed 12 Nov 2021.